Eli Lilly and Co. stock: results on October 29, 2026, slightly lower pre-market
Published on 10/19/2026 at 07:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSResults timing is confirmed
- Lilly confirmed the results announcement in an October 15, 2026 release.
- The third-quarter 2026 conference call begins at 10:00 a.m. EDT.
- Eli Lilly and Co. stock trades pre-market at EUR 1,117.60 at 7:40 a.m. CEST at Lang & Schwarz on October 19, 2026, 0.52 percent below the Xetra close of October 16, 2026.
Eli Lilly and Company said in an October 15, 2026 release that it will announce third-quarter 2026 results on October 29, 2026, with a conference call at 10:00 a.m. EDT. Eli Lilly and Company’s investor release also provides access details for the webcast. Eli Lilly and Co. stock trades pre-market at EUR 1,117.60 at 7:40 a.m. CEST at Lang & Schwarz on October 19, 2026, 0.52 percent below the Xetra close of October 16, 2026 (EUR 1,123.40).
Results date and call
The company’s release set October 29, 2026, as the publication date for its third-quarter financial results. The conference call is scheduled for 10:00 a.m. EDT on the same day, according to Eli Lilly and Company.
Ahead of the Xetra open
The Lang & Schwarz indication is minus EUR 5.80 relative to the October 16 Xetra close. The continuously updated real-time quote of Eli Lilly stock shows the further course from the Xetra open at 9:00 a.m. CEST.
Business and the day
Eli Lilly develops and sells medicines for areas including diabetes, obesity, Alzheimer’s disease, immune disorders and cancer, as described in the company’s investor release. The next company-specific date is October 29, 2026, for the third-quarter results announcement and conference call. Market context: Market report S&P 500.
